当前位置: X-MOL 学术Cell Metab. › 论文详情
Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance
Cell Metabolism ( IF 20.565 ) Pub Date : 2018-05-31 , DOI: 10.1016/j.cmet.2018.05.005
Hideki Iwamoto, Mitsuhiko Abe, Yunlong Yang, Dongmei Cui, Takahiro Seki, Masaki Nakamura, Kayoko Hosaka, Sharon Lim, Jieyu Wu, Xingkang He, Xiaoting Sun, Yongtian Lu, Qingjun Zhou, Weiyun Shi, Takuji Torimura, Guohui Nie, Qi Li, Yihai Cao

Intrinsic and evasive antiangiogenic drug (AAD) resistance is frequently developed in cancer patients, and molecular mechanisms underlying AAD resistance remain largely unknown. Here we describe AAD-triggered, lipid-dependent metabolic reprogramming as an alternative mechanism of AAD resistance. Unexpectedly, tumor angiogenesis in adipose and non-adipose environments is equally sensitive to AAD treatment. AAD-treated tumors in adipose environment show accelerated growth rates in the presence of a minimal number of microvessels. Mechanistically, AAD-induced tumor hypoxia initiates the fatty acid oxidation metabolic reprogramming and increases uptake of free fatty acid (FFA) that stimulates cancer cell proliferation. Inhibition of carnitine palmitoyl transferase 1A (CPT1) significantly compromises the FFA-induced cell proliferation. Genetic and pharmacological loss of CPT1 function sensitizes AAD therapeutic efficacy and enhances its anti-tumor effects. Together, we propose an effective cancer therapy concept by combining drugs that target angiogenesis and lipid metabolism.
更新日期:2018-05-31

 

分享到
评论: 0
期刊列表
BMC Chemistry
Nature Pig Research
中山大学化学工程与技术学院诚聘腐蚀与防护相关专业人才
西湖大学邓力教授课题组招聘启事
【问答】请问如何学会分析锂空电池测试中的问题?
天合科研
2017年中科院JCR分区化学大类列表
试剂库存管理
化合物查询
Nature
Nature
nature
down
wechat
bug